Cargando…
Adaptive platform trials using multi-arm, multi-stage protocols: getting fast answers in pandemic settings
Global health pandemics, such as coronavirus disease 2019 (COVID-19), require efficient and well-conducted trials to determine effective interventions, such as treatments and vaccinations. Early work focused on rapid sequencing of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), subsequ...
Autores principales: | Noor, Nurulamin M., Pett, Sarah L., Esmail, Hanif, Crook, Angela M., Vale, Claire L., Sydes, Matthew R., Parmar, Mahesh K.B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596806/ https://www.ncbi.nlm.nih.gov/pubmed/33149899 http://dx.doi.org/10.12688/f1000research.26253.2 |
Ejemplares similares
-
Uptake of the multi-arm multi-stage (MAMS) adaptive platform approach: a trial-registry review of late-phase randomised clinical trials
por: Noor, Nurulamin M, et al.
Publicado: (2022) -
The need for a cultural shift from two-arm to multi-arm RCTS
por: Sydes, Matthew R, et al.
Publicado: (2013) -
Combining factorial and multi-arm multi-stage platform designs to
evaluate multiple interventions efficiently
por: White, Ian R, et al.
Publicado: (2022) -
Incorporating Biomarker Stratification into STAMPEDE: an Adaptive Multi-arm, Multi-stage Trial Platform
por: Gilson, C., et al.
Publicado: (2017) -
Is It Possible to Conduct a Multi-Arm Multi-Stage Platform Trial in Parkinson’s Disease: Lessons Learned from Other Neurodegenerative Disorders and Cancer
por: Zeissler, Marie-Louise, et al.
Publicado: (2020)